Envelope glycoproteins sampling states 2/3 are susceptible to ADCC by sera from HIV-1-infected individuals

Virology

Volumn 515, Issue , 2018, Pages 38-45

  Prévost, Jérémie ^a,b   Richard, Jonathan ^a,b   Ding, Shilei ^a,b   Pacheco, Beatriz ^a   Charlebois, Roxanne ^a   Hahn, Beatrice H ^c   Kaufmann, Daniel E ^a,b,d   Finzi, Andrés ^a,b,e  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

ADCC; CD4; Envelope glycoproteins; HIV 1; Non neutralizing antibodies; States 2 3

Indexed keywords

GLYCOPROTEIN GP 120; VIRUS GLYCOPROTEIN; CD4 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; EMBRYO; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFORMED CONSENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; VIRUS PATHOGENESIS; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PHYSIOLOGY; SERUM; VIROLOGY;

ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CD4 ANTIGENS; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; SERUM;

EID: 85038864598     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2017.12.002     Document Type: Article

References (53)

1. Allan, J.S., Coligan, J.E., Barin, F., McLane, M.F., Sodroski, J.G., Rosen, C.A., Haseltine, W.A., Lee, T.H., Essex, M., Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science 228 (1985), 1091–1094.
2. Alvarez, R.A., Hamlin, R.E., Monroe, A., Moldt, B., Hotta, M.T., Rodriguez Caprio, G., Fierer, D.S., Simon, V., Chen, B.K., HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells. J. Virol. 88 (2014), 6031–6046.
3. Arias, J.F., Heyer, L.N., von Bredow, B., Weisgrau, K.L., Moldt, B., Burton, D.R., Rakasz, E.G., Evans, D.T., Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 111 (2014), 6425–6430.
4. Bar, K.J., Tsao, C.Y., Iyer, S.S., Decker, J.M., Yang, Y., Bonsignori, M., Chen, X., Hwang, K.K., Montefiori, D.C., Liao, H.X., Hraber, P., Fischer, W., Li, H., Wang, S., Sterrett, S., Keele, B.F., Ganusov, V.V., Perelson, A.S., Korber, B.T., Georgiev, I., McLellan, J.S., Pavlicek, J.W., Gao, F., Haynes, B.F., Hahn, B.H., Kwong, P.D., Shaw, G.M., Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape. PLoS Pathog., 8, 2012, e1002721.
5. Bradley, T., Trama, A., Tumba, N., Gray, E., Lu, X., Madani, N., Jahanbakhsh, F., Eaton, A., Xia, S.M., Parks, R., Lloyd, K.E., Sutherland, L.L., Scearce, R.M., Bowman, C.M., Barnett, S., Abdool-Karim, S.S., Boyd, S.D., Melillo, B., Smith, A.B. 3rd, Sodroski, J., Kepler, T.B., Alam, S.M., Gao, F., Bonsignori, M., Liao, H.X., Moody, M.A., Montefiori, D., Santra, S., Morris, L., Haynes, B.F., Amino acid changes in the HIV-1 gp41 membrane proximal region control virus neutralization sensitivity. EBioMedicine 12 (2016), 196–207.
6. Chan, D.C., Fass, D., Berger, J.M., Kim, P.S., Core structure of gp41 from the HIV envelope glycoprotein. Cell 89 (1997), 263–273.
7. Cimbro, R., Peterson, F.C., Liu, Q., Guzzo, C., Zhang, P., Miao, H., Van Ryk, D., Ambroggio, X., Hurt, D.E., De Gioia, L., Volkman, B.F., Dolan, M.A., Lusso, P., Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry. EBioMedicine 10 (2016), 45–54.
8. Ding, S., Tolbert, W.D., Prevost, J., Pacheco, B., Coutu, M., Debbeche, O., Xiang, S.H., Pazgier, M., Finzi, A., A highly conserved gp120 inner domain residue modulates Env conformation and trimer stability. J Virol., 2016.
9. Ding, S., Veillette, M., Coutu, M., Prevost, J., Scharf, L., Bjorkman, P.J., Ferrari, G., Robinson, J.E., Sturzel, C., Hahn, B.H., Sauter, D., Kirchhoff, F., Lewis, G.K., Pazgier, M., Finzi, A., A highly conserved residue of the HIV-1 gp120 inner domain is important for antibody-dependent cellular cytotoxicity responses mediated by anti-cluster A antibodies. J. Virol. 90 (2016), 2127–2134.
10. Ding, S., Verly, M.M., Princiotto, A., Melillo, B., Moody, T., Bradley, T., Easterhoff, D., Roger, M., Hahn, B.H., Madani, N., Smith Iii, A.B., Haynes, B.F., Sodroski, J.M.D., Finzi, A., Small molecule CD4-mimetics sensitize HIV-1-infected cells to ADCC by antibodies elicited by multiple envelope glycoprotein immunogens in non-human primates. AIDS Res. Hum. Retroviruses, 2016.
11. Duenas-Decamp, M., Jiang, L., Bolon, D., Clapham, P.R., Saturation mutagenesis of the HIV-1 envelope CD4 binding loop reveals residues controlling distinct trimer conformations. PLoS Pathog., 12, 2016, e1005988.
12. Fenton-May, A.E., Dibben, O., Emmerich, T., Ding, H., Pfafferott, K., Aasa-Chapman, M.M., Pellegrino, P., Williams, I., Cohen, M.S., Gao, F., Shaw, G.M., Hahn, B.H., Ochsenbauer, C., Kappes, J.C., Borrow, P., Relative resistance of HIV-1 founder viruses to control by interferon-alpha. Retrovirology, 10, 2013, 146.
13. Finzi, A., Xiang, S.H., Pacheco, B., Wang, L., Haight, J., Kassa, A., Danek, B., Pancera, M., Kwong, P.D., Sodroski, J., Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions. Mol. Cell 37 (2010), 656–667.
14. Fontaine, J., Chagnon-Choquet, J., Valcke, H.S., Poudrier, J., Roger, M., Montreal Primary, H.I.V.I., Long-Term Non-Progressor Study, G., High expression levels of B lymphocyte stimulator (BLyS) by dendritic cells correlate with HIV-related B-cell disease progression in humans. Blood 117 (2011), 145–155.
15. Fontaine, J., Coutlee, F., Tremblay, C., Routy, J.P., Poudrier, J., Roger, M., Montreal Primary, H.I.V.I., Long-Term Nonprogressor Study, G., HIV infection affects blood myeloid dendritic cells after successful therapy and despite nonprogressing clinical disease. J. Infect. Dis. 199 (2009), 1007–1018.
16. Herschhorn, A., Gu, C., Moraca, F., Ma, X., Farrell, M., Smith, A.B. 3rd, Pancera, M., Kwong, P.D., Schon, A., Freire, E., Abrams, C., Blanchard, S.C., Mothes, W., Sodroski, J.G., The beta20-beta21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions. Nat. Commun., 8, 2017, 1049.
17. Herschhorn, A., Ma, X., Gu, C., Ventura, J.D., Castillo-Menendez, L., Melillo, B., Terry, D.S., Smith, A.B. 3rd, Blanchard, S.C., Munro, J.B., Mothes, W., Finzi, A., Sodroski, J., Release of gp120 restraints leads to an entry-competent intermediate state of the HIV-1 envelope glycoproteins. mBio, 7, 2016.
18. International, H.I.V.C.S., Pereyra, F., Jia, X., McLaren, P.J., Telenti, A., de Bakker, P.I., Walker, B.D., Ripke, S., Brumme, C.J., Pulit, S.L., Carrington, M., Kadie, C.M., Carlson, J.M., Heckerman, D., Graham, R.R., Plenge, R.M., Deeks, S.G., Gianniny, L., Crawford, G., Sullivan, J., Gonzalez, E., Davies, L., Camargo, A., Moore, J.M., Beattie, N., Gupta, S., Crenshaw, A., Burtt, N.P., Guiducci, C., Gupta, N., Gao, X., Qi, Y., Yuki, Y., Piechocka-Trocha, A., Cutrell, E., Rosenberg, R., Moss, K.L., Lemay, P., O'Leary, J., Schaefer, T., Verma, P., Toth, I., Block, B., Baker, B., Rothchild, A., Lian, J., Proudfoot, J., Alvino, D.M., Vine, S., Addo, M.M., Allen, T.M., Altfeld, M., Henn, M.R., Le Gall, S., Streeck, H., Haas, D.W., Kuritzkes, D.R., Robbins, G.K., Shafer, R.W., Gulick, R.M., Shikuma, C.M., Haubrich, R., Riddler, S., Sax, P.E., Daar, E.S., Ribaudo, H.J., Agan, B., Agarwal, S., Ahern, R.L., Allen, B.L., Altidor, S., Altschuler, E.L., Ambardar, S., Anastos, K., Anderson, B., Anderson, V., Andrady, U., Antoniskis, D., Bangsberg, D., Barbaro, D., Barrie, W., Bartczak, J., Barton, S., Basden, P., Basgoz, N., Bazner, S., Bellos, N.C., Benson, A.M., Berger, J., Bernard, N.F., Bernard, A.M., Birch, C., Bodner, S.J., Bolan, R.K., Boudreaux, E.T., Bradley, M., Braun, J.F., Brndjar, J.E., Brown, S.J., Brown, K., Brown, S.T., Burack, J., Bush, L.M., Cafaro, V., Campbell, O., Campbell, J., Carlson, R.H., Carmichael, J.K., Casey, K.K., Cavacuiti, C., Celestin, G., Chambers, S.T., Chez, N., Chirch, L.M., Cimoch, P.J., Cohen, D., Cohn, L.E., Conway, B., Cooper, D.A., Cornelson, B., Cox, D.T., Cristofano, M.V., Cuchural, G. Jr., Czartoski, J.L., Dahman, J.M., Daly, J.S., Davis, B.T., Davis, K., Davod, S.M., DeJesus, E., Dietz, C.A., Dunham, E., Dunn, M.E., Ellerin, T.B., Eron, J.J., Fangman, J.J., Farel, C.E., Ferlazzo, H., Fidler, S., Fleenor-Ford, A., Frankel, R., Freedberg, K.A., French, N.K., Fuchs, J.D., Fuller, J.D., Gaberman, J., Gallant, J.E., Gandhi, R.T., Garcia, E., Garmon, D., Gathe, J.C. Jr., Gaultier, C.R., Gebre, W., Gilman, F.D., Gilson, I., Goepfert, P.A., Gottlieb, M.S., Goulston, C., Groger, R.K., Gurley, T.D., Haber, S., Hardwicke, R., Hardy, W.D., Harrigan, P.R., Hawkins, T.N., Heath, S., Hecht, F.M., Henry, W.K., Hladek, M., Hoffman, R.P., Horton, J.M., Hsu, R.K., Huhn, G.D., Hunt, P., Hupert, M.J., Illeman, M.L., Jaeger, H., Jellinger, R.M., John, M., Johnson, J.A., Johnson, K.L., Johnson, H., Johnson, K., Joly, J., Jordan, W.C., Kauffman, C.A., Khanlou, H., Killian, R.K., Kim, A.Y., Kim, D.D., Kinder, C.A., Kirchner, J.T., Kogelman, L., Kojic, E.M., Korthuis, P.T., Kurisu, W., Kwon, D.S., LaMar, M., Lampiris, H., Lanzafame, M., Lederman, M.M., Lee, D.M., Lee, J.M., Lee, M.J., Lee, E.T., Lemoine, J., Levy, J.A., Llibre, J.M., Liguori, M.A., Little, S.J., Liu, A.Y., Lopez, A.J., Loutfy, M.R., Loy, D., Mohammed, D.Y., Man, A., Mansour, M.K., Marconi, V.C., Markowitz, M., Marques, R., Martin, J.N., Martin, H.L. Jr., Mayer, K.H., McElrath, M.J., McGhee, T.A., McGovern, B.H., McGowan, K., McIntyre, D., McLeod, G.X., Menezes, P., Mesa, G., Metroka, C.E., Meyer-Olson, D., Miller, A.O., Montgomery, K., Mounzer, K.C., Nagami, E.H., Nagin, I., Nahass, R.G., Nelson, M.O., Nielsen, C., Norene, D.L., O'Connor, D.H., Ojikutu, B.O., Okulicz, J., Oladehin, O.O., Oldfield, E.C. 3rd, Olender, S.A., Ostrowski, M., Owen, W.F. Jr., Pae, E., Parsonnet, J., Pavlatos, A.M., Perlmutter, A.M., Pierce, M.N., Pincus, J.M., Pisani, L., Price, L.J., Proia, L., Prokesch, R.C., Pujet, H.C., Ramgopal, M., Rathod, A., Rausch, M., Ravishankar, J., Rhame, F.S., Richards, C.S., Richman, D.D., Rodes, B., Rodriguez, M., Rose, R.C. 3rd, Rosenberg, E.S., Rosenthal, D., Ross, P.E., Rubin, D.S., Rumbaugh, E., Saenz, L., Salvaggio, M.R., Sanchez, W.C., Sanjana, V.M., Santiago, S., Schmidt, W., Schuitemaker, H., Sestak, P.M., Shalit, P., Shay, W., Shirvani, V.N., Silebi, V.I., Sizemore, J.M. Jr., Skolnik, P.R., Sokol-Anderson, M., Sosman, J.M., Stabile, P., Stapleton, J.T., Starrett, S., Stein, F., Stellbrink, H.J., Sterman, F.L., Stone, V.E., Stone, D.R., Tambussi, G., Taplitz, R.A., Tedaldi, E.M., Telenti, A., Theisen, W., Torres, R., Tosiello, L., Tremblay, C., Tribble, M.A., Trinh, P.D., Tsao, A., Ueda, P., Vaccaro, A., Valadas, E., Vanig, T.J., Vecino, I., Vega, V.M., Veikley, W., Wade, B.H., Walworth, C., Wanidworanun, C., Ward, D.J., Warner, D.A., Weber, R.D., Webster, D., Weis, S., Wheeler, D.A., White, D.J., Wilkins, E., Winston, A., Wlodaver, C.G., van't Wout, A., Wright, D.P., Yang, O.O., Yurdin, D.L., Zabukovic, B.W., Zachary, K.C., Zeeman, B., Zhao, M., The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330 (2010), 1551–1557.
19. Julien, J.P., Cupo, A., Sok, D., Stanfield, R.L., Lyumkis, D., Deller, M.C., Klasse, P.J., Burton, D.R., Sanders, R.W., Moore, J.P., Ward, A.B., Wilson, I.A., Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science, 2013.
20. Kamya, P., Boulet, S., Tsoukas, C.M., Routy, J.P., Thomas, R., Cote, P., Boulassel, M.R., Baril, J.G., Kovacs, C., Migueles, S.A., Connors, M., Suscovich, T.J., Brander, C., Tremblay, C.L., Bernard, N., Canadian Cohort of, H.I.V.I.S.P., Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57. J. Virol. 85 (2011), 5949–5960.
21. Kwon, Y.D., Finzi, A., Wu, X., Dogo-Isonagie, C., Lee, L.K., Moore, L.R., Schmidt, S.D., Stuckey, J., Yang, Y., Zhou, T., Zhu, J., Vicic, D.A., Debnath, A.K., Shapiro, L., Bewley, C.A., Mascola, J.R., Sodroski, J.G., Kwong, P.D., Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops. Proc. Natl. Acad. Sci. USA 109 (2012), 5663–5668.
22. Lewis, G.K., Finzi, A., DeVico, A.L., Pazgier, M., Conformational masking and receptor-dependent unmasking of highly conserved Env epitopes recognized by non-neutralizing antibodies that mediate potent ADCC against HIV-1. Viruses 7 (2015), 5115–5132.
23. Lewis, G.K., Pazgier, M., Evans, D., Ferrari, G., Bournazos, S., Parsons, M.S., Bernard, N.F., Finzi, A., Beyond viral neutralization. AIDS Res. Hum. Retroviruses, 2017.
24. Liu, J., Bartesaghi, A., Borgnia, M.J., Sapiro, G., Subramaniam, S., Molecular architecture of native HIV-1 gp120 trimers. Nature 455 (2008), 109–113.
25. Lu, M., Blacklow, S.C., Kim, P.S., A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2 (1995), 1075–1082.
26. Lyumkis, D., Julien, J.P., de Val, N., Cupo, A., Potter, C.S., Klasse, P.J., Burton, D.R., Sanders, R.W., Moore, J.P., Carragher, B., Wilson, I.A., Ward, A.B., Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science, 2013.
27. Madani, N., Princiotto, A.M., Easterhoff, D., Bradley, T., Luo, K., Williams, W.B., Liao, H.X., Moody, M.A., Phad, G.E., Vazquez Bernat, N., Melillo, B., Santra, S., Smith, A.B. 3rd, Karlsson Hedestam, G.B., Haynes, B., Sodroski, J., Antibodies elicited by multiple envelope glycoprotein immunogens in primates neutralize primary human immunodeficiency viruses (HIV-1) sensitized by CD4-mimetic compounds. J. Virol. 90 (2016), 5031–5046.
28. Mao, Y., Wang, L., Gu, C., Herschhorn, A., Xiang, S.H., Haim, H., Yang, X., Sodroski, J., Subunit organization of the membrane-bound HIV-1 envelope glycoprotein trimer. Nat. Struct. Mol. Biol. 19 (2012), 893–899.
29. Medjahed, H., Pacheco, B., Desormeaux, A., Sodroski, J., Finzi, A., The HIV-1 gp120 major variable regions modulate cold inactivation. J. Virol. 87 (2013), 4103–4111.
30. Munro, J.B., Gorman, J., Ma, X., Zhou, Z., Arthos, J., Burton, D.R., Koff, W.C., Courter, J.R., Smith, A.B. 3rd, Kwong, P.D., Blanchard, S.C., Mothes, W., Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions. Science 346 (2014), 759–763.
31. O'Rourke, S.M., Schweighardt, B., Phung, P., Mesa, K.A., Vollrath, A.L., Tatsuno, G.P., To, B., Sinangil, F., Limoli, K., Wrin, T., Berman, P.W., Sequences in glycoproteingp41, the CD4 binding site, and the V2 domain regulate sensitivity and resistance of HIV-1 to broadly neutralizing antibodies. J. Virol. 86 (2012), 12105–12114.
32. Ochsenbauer, C., Edmonds, T.G., Ding, H., Keele, B.F., Decker, J., Salazar, M.G., Salazar-Gonzalez, J.F., Shattock, R., Haynes, B.F., Shaw, G.M., Hahn, B.H., Kappes, J.C., Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J. Virol. 86 (2012), 2715–2728.
33. Pancera, M., Zhou, T., Druz, A., Georgiev, I.S., Soto, C., Gorman, J., Huang, J., Acharya, P., Chuang, G.Y., Ofek, G., Stewart-Jones, G.B., Stuckey, J., Bailer, R.T., Joyce, M.G., Louder, M.K., Tumba, N., Yang, Y., Zhang, B., Cohen, M.S., Haynes, B.F., Mascola, J.R., Morris, L., Munro, J.B., Blanchard, S.C., Mothes, W., Connors, M., Kwong, P.D., Structure and immune recognition of trimeric pre-fusion HIV-1 Env. Nature 514 (2014), 455–461.
34. Parrish, N.F., Gao, F., Li, H., Giorgi, E.E., Barbian, H.J., Parrish, E.H., Zajic, L., Iyer, S.S., Decker, J.M., Kumar, A., Hora, B., Berg, A., Cai, F., Hopper, J., Denny, T.N., Ding, H., Ochsenbauer, C., Kappes, J.C., Galimidi, R.P., West, A.P. Jr., Bjorkman, P.J., Wilen, C.B., Doms, R.W., O'Brien, M., Bhardwaj, N., Borrow, P., Haynes, B.F., Muldoon, M., Theiler, J.P., Korber, B., Shaw, G.M., Hahn, B.H., Phenotypic properties of transmitted founder HIV-1. Proc. Natl. Acad. Sci. USA 110 (2013), 6626–6633.
35. Peretz, Y., Ndongala, M.L., Boulet, S., Boulassel, M.R., Rouleau, D., Cote, P., Longpre, D., Routy, J.P., Falutz, J., Tremblay, C., Tsoukas, C.M., Sekaly, R.P., Bernard, N.F., Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression. Clin. Immunol. 124 (2007), 57–68.
36. Prevost, J., Zoubchenok, D., Richard, J., Veillette, M., Pacheco, B., Coutu, M., Brassard, N., Parsons, M.S., Ruxrungtham, K., Bunupuradah, T., Tovanabutra, S., Hwang, K.K., Moody, M.A., Haynes, B.F., Bonsignori, M., Sodroski, J., Kaufmann, D.E., Shaw, G.M., Chenine, A.L., Finzi, A., Influence of the envelope gp120 Phe 43 cavity on HIV-1 sensitivity to antibody-dependent cell-mediated cytotoxicity responses. J. Virol., 91, 2017.
37. Richard, J., Pacheco, B., Gohain, N., Veillette, M., Ding, S., Alsahafi, N., Tolbert, W.D., Prevost, J., Chapleau, J.P., Coutu, M., Jia, M., Brassard, N., Park, J., Courter, J.R., Melillo, B., Martin, L., Tremblay, C., Hahn, B.H., Kaufmann, D.E., Wu, X., Smith, A.B., 3rd, Sodroski, J., Pazgier, M., Finzi, A., 2016a. Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins. EBioMedicine.
38. Richard, J., Prevost, J., von Bredow, B., Ding, S., Brassard, N., Medjahed, H., Coutu, M., Melillo, B., Bibollet-Ruche, F., Hahn, B.H., Kaufmann, D.E., Smith, A.B. 3rd, Sodroski, J., Sauter, D., Kirchhoff, F., Gee, K., Neil, S.J., Evans, D.T., Finzi, A., BST-2 expression Modulates small CD4-mimetic sensitization of HIV-1-infected cells to antibody-dependent cellular cytotoxicity. J. Virol., 91, 2017.
39. Richard, J., Sindhu, S., Pham, T.N., Belzile, J.P., Cohen, E.A., HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. Blood 115 (2010), 1354–1363.
40. Richard, J., Veillette, M., Batraville, L.A., Coutu, M., Chapleau, J.P., Bonsignori, M., Bernard, N., Tremblay, C., Roger, M., Kaufmann, D.E., Finzi, A., Flow cytometry-based assay to study HIV-1gp120 specific antibody-dependent cellular cytotoxicity responses. J. Virol. Methods 208 (2014), 107–114.
41. Richard, J., Veillette, M., Brassard, N., Iyer, S.S., Roger, M., Martin, L., Pazgier, M., Schon, A., Freire, E., Routy, J.P., Smith, A.B. 3rd, Park, J., Jones, D.M., Courter, J.R., Melillo, B.N., Kaufmann, D.E., Hahn, B.H., Permar, S.R., Haynes, B.F., Madani, N., Sodroski, J.G., Finzi, A., CD4 mimetics sensitize HIV-1-infected cells to ADCC. Proc. Natl. Acad. Sci. USA 112 (2015), E2687–E2694.
42. Richard, J., Veillette, M., Ding, S., Zoubchenok, D., Alsahafi, N., Coutu, M., Brassard, N., Park, J., Courter, J.R., Melillo, B., Smith, A.B. 3rd, Shaw, G.M., Hahn, B.H., Sodroski, J., Kaufmann, D.E., Finzi, A., Small CD4 mimetics prevent HIV-1 uninfected bystander CD4 + T cell killing mediated by antibody-dependent cell-mediated cytotoxicity. EBioMedicine 3 (2016), 122–134.
43. Robey, W.G., Safai, B., Oroszlan, S., Arthur, L.O., Gonda, M.A., Gallo, R.C., Fischinger, P.J., Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science 228 (1985), 593–595.
44. Tolbert, W.D., Gohain, N., Alsahafi, N., Van, V., Orlandi, C., Ding, S., Martin, L., Finzi, A., Lewis, G.K., Ray, K., Pazgier, M., Targeting the late stage of HIV-1 entry for antibody-dependent cellular cytotoxicity: structural basis for Env epitopes in the C11 region. Structure, 2017.
45. Veillette, M., Coutu, M., Richard, J., Batraville, L.A., Dagher, O., Bernard, N., Tremblay, C., Kaufmann, D.E., Roger, M., Finzi, A., The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals. J. Virol. 89 (2015), 545–551.
46. Veillette, M., Coutu, M., Richard, J., Batraville, L.A., Desormeaux, A., Roger, M., Finzi, A., Conformational evaluation of HIV-1 trimeric envelope glycoproteins using a cell-based ELISA assay. J. Vis. Exp.: JoVE, 2014, 51995.
47. Veillette, M., Desormeaux, A., Medjahed, H., Gharsallah, N.E., Coutu, M., Baalwa, J., Guan, Y., Lewis, G., Ferrari, G., Hahn, B.H., Haynes, B.F., Robinson, J.E., Kaufmann, D.E., Bonsignori, M., Sodroski, J., Finzi, A., Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity. J. Virol. 88 (2014), 2633–2644.
48. Veillette, M., Richard, J., Pazgier, M., Lewis, G.K., Parsons, M.S., Finzi, A., Role of HIV-1 Envelope Glycoproteins Conformation and Accessory Proteins on ADCC Responses. Curr. HIV Res. 14 (2016), 9–23.
49. von Bredow, B., Arias, J.F., Heyer, L.N., Gardner, M.R., Farzan, M., Rakasz, E.G., Evans, D.T., Envelope glycoprotein internalization protects human and simian immunodeficiency virus infected cells from antibody-dependent cell-mediated cytotoxicity. J Virol., 2015.
50. von Bredow, B., Arias, J.F., Heyer, L.N., Moldt, B., Le, K., Robinson, J.E., Zolla-Pazner, S., Burton, D.R., Evans, D.T., Comparison of antibody-dependent cell-mediated cytotoxicity and virus neutralization by HIV-1 Env-specific monoclonal antibodies. J. Virol. 90 (2016), 6127–6139.
51. Weissenhorn, W., Dessen, A., Harrison, S.C., Skehel, J.J., Wiley, D.C., Atomic structure of the ectodomain from HIV-1 gp41. Nature 387 (1997), 426–430.
52. White, T.A., Bartesaghi, A., Borgnia, M.J., Meyerson, J.R., de la Cruz, M.J., Bess, J.W., Nandwani, R., Hoxie, J.A., Lifson, J.D., Milne, J.L., Subramaniam, S., Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure. PLoS Pathog., 6, 2010, e1001249.
53. Wyatt, R., Sodroski, J., The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280 (1998), 1884–1888.